We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

Celltrion Healthcare Australia Pty Ltd.

Regulatory activities for this sponsor.

2 result(s) found, displaying 1 to 2

Vegzelma

18 September 2023

Prescription medicine decision summary

Vegzelma (bevacizumab) is approved to treat cancer.
Regkirona

6 December 2021

Prescription medicine decision summary

Australian prescription medicine decision summary